Serveur d'exploration sur la rapamycine et les champignons - Exploration (Accueil)

Index « KwdFr.i » - entrée « Tacrolimus (pharmacologie) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Tacrolimus (pharmacocinétique) < Tacrolimus (pharmacologie) < Tacrolimus (sang)  Facettes :

List of bibliographic references indexed by Tacrolimus (pharmacologie)

Number of relevant bibliographic references: 57.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000018 (2020) Asiya Gusa [États-Unis] ; Jonathan D. Williams [États-Unis] ; Jang-Eun Cho [États-Unis] ; Anna Floyd Averette [États-Unis] ; Sheng Sun [États-Unis] ; Eva Mei Shouse [États-Unis] ; Joseph Heitman [États-Unis] ; J Andrew Alspaugh [États-Unis] ; Sue Jinks-Robertson [États-Unis]Transposon mobilization in the human fungal pathogen Cryptococcus is mutagenic during infection and promotes drug resistance in vitro.
000119 (2020) Koji Kasahara [Japon] ; Risa Nakayama [Japon] ; Yuh Shiwa [Japon] ; Yu Kanesaki [Japon] ; Taichiro Ishige [Japon] ; Hirofumi Yoshikawa [Japon] ; Tetsuro Kokubo [Japon]Fpr1, a primary target of rapamycin, functions as a transcription factor for ribosomal protein genes cooperatively with Hmo1 in Saccharomyces cerevisiae.
000228 (2019) Dora M. Berman [États-Unis] ; Phillip Ruiz [États-Unis] ; Manuel Blandino-Rosano [États-Unis] ; Ernesto Bernal-Mizrachi [États-Unis] ; Norma S. Kenyon [États-Unis]Steroid-Free Immune Suppression Impairs Glycemic Control in a Healthy Cynomolgus Monkey.
000322 (2019) Patrick Schwarz [Allemagne] ; Petra V. Schwarz [Allemagne] ; Heike Felske-Zech [Allemagne] ; Eric Dannaoui [France]In vitro interactions between isavuconazole and tacrolimus, cyclosporin A or sirolimus against Mucorales.
000358 (2019) Zanetta Chang [États-Unis] ; Joseph Heitman [États-Unis]Drug-Resistant Epimutants Exhibit Organ-Specific Stability and Induction during Murine Infections Caused by the Human Fungal Pathogen Mucor circinelloides.
000377 (2019) Zanetta Chang [États-Unis] ; R Blake Billmyre [États-Unis] ; Soo Chan Lee [États-Unis] ; Joseph Heitman [États-Unis]Broad antifungal resistance mediated by RNAi-dependent epimutation in the basal human fungal pathogen Mucor circinelloides.
000578 (2018) Johannes Korth [Allemagne] ; Olympia E. Anastasiou [Allemagne] ; Jens Verheyen [Allemagne] ; Julia Dickow [Allemagne] ; Helene Sertznig [Allemagne] ; Nicola Frericks [Allemagne] ; Barbara Bleekmann [Allemagne] ; Andreas Kribben [Allemagne] ; Alexandra Brinkhoff [Allemagne] ; Benjamin Wilde [Allemagne] ; Kathrin Sutter [Allemagne] ; Ulf Dittmer [Allemagne] ; Sandra Ciesek [Allemagne] ; Oliver Witzke [Allemagne] ; Marek Widera [Allemagne]Impact of immune suppressive agents on the BK-Polyomavirus non coding control region.
000712 (2017) Paul Monaghan [Irlande (pays)] ; Darren B. Leneghan [Irlande (pays)] ; Wesley Shaw [Irlande (pays)] ; Angus Bell [Irlande (pays)]The antimalarial action of FK506 and rapamycin: evidence for a direct effect on FK506-binding protein PfFKBP35.
000A83 (2016) Josh Levitsky [États-Unis] ; Joshua Miller [États-Unis] ; Xuemei Huang [États-Unis] ; Lorenzo Gallon [États-Unis] ; Joseph R. Leventhal [États-Unis] ; James M. Mathew [États-Unis]Immunoregulatory Effects of Everolimus on In Vitro Alloimmune Responses.
000B40 (2016) H H Hirsch [Suisse] ; K. Yakhontova [Suisse] ; M. Lu [Suisse] ; J. Manzetti [Suisse]BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12.
000D05 (2015) Eu Jin Lim [Australie] ; Ruth Chin [Australie] ; Ueli Nachbur [Australie] ; John Silke [Australie] ; Zhiyuan Jia [Australie] ; Peter W. Angus [Australie] ; Joseph Torresi [Australie]Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation.
000D15 (2015) Opas Traitanon [Thaïlande] ; James M. Mathew [États-Unis] ; Giovanna La Monica [États-Unis] ; Luting Xu [États-Unis] ; Valeria Mas [États-Unis] ; Lorenzo Gallon [États-Unis]Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells.
000D16 (2015) Lorenzo Gallon [États-Unis] ; Opas Traitanon ; Yuming Yu ; Bo Shi ; Joseph R. Leventhal ; Joshua Miller ; Valeria Mas ; Xu L ; James M. MathewDifferential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells.
000E85 (2014) Per Marits [Suède] ; Ann-Charlotte Wikström [Suède] ; Dusan Popadic [Serbie] ; Ola Winqvist [Suède] ; Sarah Thunberg [Suède]Evaluation of T and B lymphocyte function in clinical practice using a flow cytometry based proliferation assay.
001021 (2013) Andreas M. M Rz [Allemagne] ; Anne-Katrin Fabian ; Christian Kozany ; Andreas Bracher ; Felix HauschLarge FK506-binding proteins shape the pharmacology of rapamycin.
001106 (2012) Barbara Suwelack [Allemagne] ; Viola Malyar ; Martina Koch ; Martina Sester ; Claudia SommererThe influence of immunosuppressive agents on BK virus risk following kidney transplantation, and implications for choice of regimen.
001135 (2012) Robert J. Bastidas [États-Unis] ; Cecelia A. Shertz ; Soo Chan Lee ; Joseph Heitman ; Maria E. CardenasRapamycin exerts antifungal activity in vitro and in vivo against Mucor circinelloides via FKBP12-dependent inhibition of Tor.
001140 (2012) Audrey Coilly [France] ; Valérie Furlan ; Bruno Roche ; Caroline Barau ; Coralie Noël ; Laurence Bonhomme-Faivre ; Teresa Maria Antonini ; Anne-Marie Roque-Afonso ; Didier Samuel ; Anne-Marie Taburet ; Jean-Charles Duclos-ValléePractical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis C virus recurrence.
001422 (2010) S. Narreddy [États-Unis] ; E. Manavathu ; P H Chandrasekar ; G J Alangaden ; S G RevankarIn vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes.
001515 (2009) Eric Dannaoui [France] ; Patrick Schwarz ; Olivier LortholaryIn vitro interactions between antifungals and immunosuppressive drugs against zygomycetes.
001857 (2005) Shantha Kumar [États-Unis] ; Marianne J. Skeen ; Yaffa Adiri ; Hyseuk Yoon ; Vaiva D. Vezys ; Aron E. Lukacher ; Brian D. Evavold ; H Kirk Ziegler ; Jeremy M. BossA cytokine promoter/yellow fluorescent protein reporter transgene serves as an early activation marker of lymphocyte subsets.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Tacrolimus (pharmacologie)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Tacrolimus (pharmacologie)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Tacrolimus (pharmacologie)
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020